{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:57:56Z","timestamp":1759683476587},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1994,1]]},"DOI":"10.1007\/bf02245203","type":"journal-article","created":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T15:34:18Z","timestamp":1133451258000},"page":"318-321","source":"Crossref","is-referenced-by-count":14,"title":["Reduction in ATP-sensitive potassium channel-mediated antinociception in diabetic mice"],"prefix":"10.1007","volume":"113","author":[{"given":"Junzo","family":"Kamei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Narita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwa","family":"Misawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Kasuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02245203_CR1","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1126\/science.2305257","volume":"247","author":"S Amoroso","year":"1990","unstructured":"Amoroso S, Schmid-Antomarchi H, Fosset M, Lazdunski M (1990) Glucose, sulfonylureas, and neurotransmitter release: role of ATP-sensitive K+ channels, Science 247:852\u2013854","journal-title":"Science"},{"key":"BF02245203_CR2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2337\/diab.36.10.1173","volume":"36","author":"DA Brase","year":"1987","unstructured":"Brase DA, Han TH, Dewey WL (1987) Effects of glucose and diabetes on binding of naloxone and dihydromorphine to opiate receptors in mouse brain. Diabetes 36:1173\u20131177","journal-title":"Diabetes"},{"key":"BF02245203_CR3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/311271a0","volume":"311","author":"DL Cook","year":"1984","unstructured":"Cook DL, Hales N (1984) Intracellular ATP directly blocks K+ channels in pancreatic \u03b2-cells. Nature 311:271\u2013273","journal-title":"Nature"},{"key":"BF02245203_CR4","first-page":"21","volume":"9","author":"NS Cook","year":"1988","unstructured":"Cook NS (1988) The pharmacology of potassium channels and their therapeutic potential. TIPS 9:21\u201328","journal-title":"TIPS"},{"key":"BF02245203_CR5","first-page":"74","volume":"72","author":"WL D'Amour","year":"1941","unstructured":"D'Amour WL, Smith DL (1941) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74\u201379","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245203_CR6","first-page":"435","volume":"175","author":"WL Dewey","year":"1970","unstructured":"Dewey WL, Harris LS, Howes JF, Nuite JA (1970) The effect of various neurochemical modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. J. Pharmacol Exp Ther 175:435\u2013442","journal-title":"J. Pharmacol Exp Ther"},{"key":"BF02245203_CR7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01868430","volume":"88","author":"I Findlay","year":"1985","unstructured":"Findlay I, Dunne MJ, Peterson OH (1985) ATP-sensitive inward rectifier and voltage- and calcium-activated K+ channels in cultured pancreatic islet calls. J Membr Biol 88:165\u2013172","journal-title":"J Membr Biol"},{"key":"BF02245203_CR8","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.1016\/S0021-9258(18)68422-4","volume":"263","author":"M Fosset","year":"1988","unstructured":"Fosset M, De Weeille JR, Green RD, Schmid-Antomarchi H, Lazdunski M (1988) Antidiabetic sulfonylureas control action potential properties in heart cells via high affinity receptors that linked to ATP-dependent K+ channels, J Biol Chem 263:7933\u20137936","journal-title":"J Biol Chem"},{"key":"BF02245203_CR9","first-page":"12","volume":"12","author":"TJ Haley","year":"1957","unstructured":"Haley TJ, McCormick WG (1957) Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol 12:12\u201315","journal-title":"Br J Pharmacol"},{"key":"BF02245203_CR10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1113\/jphysiol.1985.sp015721","volume":"363","author":"M Kakei","year":"1985","unstructured":"Kakei M, Nama A, Shibasaki T (1985) Properties of adenosinetriphosphate-regulated potassium channels in guinea-pig ventricular cells. J Physiol 363:441\u2013462","journal-title":"J Physiol"},{"key":"BF02245203_CR11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0006-8993(92)90619-K","volume":"576","author":"J Kamei","year":"1992","unstructured":"Kamei J, Kawashima N, Kasuya Y (1992a) Role of spleen or spleen products in the deficiency in morphine-induced analgesia in diabetic mice. Brain Res 576:139\u2013142","journal-title":"Brain Res"},{"key":"BF02245203_CR12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0006-8993(92)90655-S","volume":"571","author":"J Kamei","year":"1992","unstructured":"Kamei J, Ohhashi Y, Aoki, T, Kawashima N, Kasuya Y (1992b) Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by \u03bc-opioid agonists, but not by \u03b4- and \u03ba-opioid agonists. Brain Res 571:199\u2013203","journal-title":"Brain Res"},{"key":"BF02245203_CR13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0024-3205(93)90288-E","volume":"52","author":"J Kamei","year":"1993","unstructured":"Kamei J, Kawashima N, Kasuya Y (1993) Serum glucose level-dependent and independent modulation of \u03bc-opioid agonist-mediated analgesia in diabetic mice. Life Sci 52:53\u201360","journal-title":"Life Sci"},{"key":"BF02245203_CR14","doi-asserted-by":"crossref","unstructured":"Narita M, Takamori K, Kawashima N, Funada M, Kamei J, Suzuki T, Misawa M, Nagase H (1993) Activation of central ATP-sensitive potassium channels produces the antinociception and spinal noradrenaline turnover-enhancing effect in mice. Psychopharmacology (in press)","DOI":"10.1007\/BF02244326"},{"key":"BF02245203_CR15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/305147a0","volume":"305","author":"A Noma","year":"1983","unstructured":"Noma A (1983) ATP-regulated K+ channels in cardiac muscle. Nature 305:147\u2013148","journal-title":"Nature"},{"key":"BF02245203_CR16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0014-2999(90)90466-J","volume":"186","author":"M Ocana","year":"1990","unstructured":"Ocana M, Pozo ED, Barrios M, Robles LI, Baeyens JM (1990) An ATP-dependent potassium channel blocker antagonizes morphine analgesia. Eur J Pharmacol 186:377\u2013378","journal-title":"Eur J Pharmacol"},{"key":"BF02245203_CR17","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1152\/physrev.1987.67.3.1054","volume":"67","author":"OH Petersen","year":"1987","unstructured":"Petersen OH, Findlay I (1987) Electrophysiology of the pancreas. Physiol Rev 67:1054\u20131116","journal-title":"Physiol Rev"},{"key":"BF02245203_CR18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0014-2999(83)90568-X","volume":"90","author":"IS Singh","year":"1983","unstructured":"Singh IS, Chaterjee TK, Ghosh JJ (1983) Modification of morphine antinociceptive response by blood glucose status: possible involvement of cellular energetics. Eur J Pharmacol 90:437\u2013439","journal-title":"Eur J Pharmacol"},{"key":"BF02245203_CR19","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/316736a0","volume":"316","author":"AE Spruce","year":"1985","unstructured":"Spruce AE, Standen NB, Stanfield PR (1985) Voltage-dependent ATP-sensitive potassium channels of skeletal muscle membrane. Nature 316:736\u2013738","journal-title":"Nature"},{"key":"BF02245203_CR20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.2501869","volume":"245","author":"NB Standen","year":"1989","unstructured":"Standen NB, Quayle JM, Davies NW, Brayden JE, Huang Y, Nelson MT (1989) Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science 245:177\u2013180","journal-title":"Science"},{"key":"BF02245203_CR21","first-page":"335","volume":"10","author":"PR Stanfield","year":"1987","unstructured":"Stanfield PR (1987) Nucleotides such as ATP may control the activity of ion channels. TINS 10:335\u2013339","journal-title":"TINS"},{"key":"BF02245203_CR22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0304-3940(83)90402-0","volume":"42","author":"MA Werz","year":"1983","unstructured":"Werz MA, MacDonald RL (1983) Opioid peptides selective for \u03bc-and \u03b4-opate receptors reduce calcium-dependent action potential duration by increasing potassium conductance. Neurosci Lett 42:173\u2013178","journal-title":"Neurosci Lett"},{"key":"BF02245203_CR23","first-page":"49","volume":"234","author":"MA Werz","year":"1985","unstructured":"Werz MA, MacDonold RL (1985) Dynorphin and neoendorphin peptides decrease dorsal root ganglion neuron calcium-dependent action potential duration. J Pharmacol Exp Ther 234:49\u201356","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245203_CR24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0014-2999(91)90215-C","volume":"193","author":"KD Wild","year":"1991","unstructured":"Wild KD, Vanderah T, Mosberg HI, Porreca F (1991) Opioid \u03b4 receptor subtypes are associated with different potassium channels. Eur J Pharmacol 193:135\u2013136","journal-title":"Eur J Pharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02245203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02245203\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02245203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T21:13:09Z","timestamp":1626815589000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02245203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,1]]},"references-count":24,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[1994,1]]}},"alternative-id":["BF02245203"],"URL":"https:\/\/doi.org\/10.1007\/bf02245203","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,1]]}}}